Novel Bruton’s Tyrosine Kinase inhibitor remibrutinib: Drug‐drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling

by Felix Huth, Hilmar Schiller, Yi Jin, Birk Poller, Carole Schuhler, Wendy Weis, Ralph Woessner, Anton Drollmann, Peter End
Published 2022-01-01

Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize It...

by Yan Ji, Claudio Calonder, Tiina Kirsilä, Alis Burciu, Matjaz Tisu, Yolandi Joubert, Nathalie Laurent, Eva Hua, Manmath Patekar, Anton Drollmann, Ralph Woessner
Published 2023-09-01

Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial

by Dave Singh, Jim M. Wild, Dinesh Saralaya, Rod Lawson, Helen Marshall, Jonathan Goldin, Matthew S. Brown, Konstantinos Kostikas, Kristin Belmore, Robert Fogel, Francesco Patalano, Anton Drollmann, Surendra Machineni, Ieuan Jones, Denise Yates, Hanns-Christian Tillmann
Published 2022-02-01